However, the extent of the sensitivity of these two agents increased in Mus81‐disrupted HCT116 colon cancer cells was significantly higher than other agents such as methylmethane sulfonate (MMS) and hydroxyurea 16. The gene discussed is MUS81; the disease is malignant colon neoplasm.